ReviewFrontiers in immunology2020

Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring.

Kathy Khoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.